Allianz Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-16,168
Closed -$46K 2128
2020
Q1
$46K Sell
16,168
-22,124
-58% -$62.9K ﹤0.01% 1945
2019
Q4
$125K Sell
38,292
-353
-0.9% -$1.15K ﹤0.01% 2176
2019
Q3
$83K Sell
38,645
-80,796
-68% -$174K ﹤0.01% 2178
2019
Q2
$375K Sell
119,441
-17,840
-13% -$56K ﹤0.01% 2004
2019
Q1
$511K Sell
137,281
-217,366
-61% -$809K ﹤0.01% 1944
2018
Q4
$1.03M Sell
354,647
-14,328
-4% -$41.5K ﹤0.01% 1672
2018
Q3
$970K Sell
368,975
-195,059
-35% -$513K ﹤0.01% 1786
2018
Q2
$1.32M Sell
564,034
-370,051
-40% -$865K ﹤0.01% 1654
2018
Q1
$2.75M Sell
934,085
-28,183
-3% -$82.9K ﹤0.01% 1399
2017
Q4
$2.64M Buy
962,268
+21,180
+2% +$58K ﹤0.01% 1448
2017
Q3
$3.19M Buy
941,088
+146,817
+18% +$498K ﹤0.01% 1350
2017
Q2
$1.98M Sell
794,271
-24,792
-3% -$61.9K ﹤0.01% 1483
2017
Q1
$1.86M Sell
819,063
-57,413
-7% -$130K ﹤0.01% 1523
2016
Q4
$1.86M Buy
876,476
+394,938
+82% +$837K ﹤0.01% 1502
2016
Q3
$1.58M Buy
481,538
+110,369
+30% +$363K ﹤0.01% 1568
2016
Q2
$1.17M Buy
371,169
+39,455
+12% +$124K ﹤0.01% 1610
2016
Q1
$1.11M Buy
331,714
+150,479
+83% +$501K ﹤0.01% 1551
2015
Q4
$642K Sell
181,235
-15,460
-8% -$54.8K ﹤0.01% 1664
2015
Q3
$990K Sell
196,695
-475,617
-71% -$2.39M ﹤0.01% 1507
2015
Q2
$4.32M Sell
672,312
-881,338
-57% -$5.67M ﹤0.01% 1160
2015
Q1
$10.9M Sell
1,553,650
-963,150
-38% -$6.78M 0.01% 792
2014
Q4
$19.4M Buy
2,516,800
+998,239
+66% +$7.7M 0.02% 629
2014
Q3
$11.3M Buy
1,518,561
+88,635
+6% +$662K 0.01% 730
2014
Q2
$13.8M Buy
1,429,926
+776,415
+119% +$7.52M 0.02% 656
2014
Q1
$5.43M Sell
653,511
-53,039
-8% -$441K 0.01% 925
2013
Q4
$5.96M Buy
706,550
+138,403
+24% +$1.17M 0.01% 886
2013
Q3
$4.53M Buy
568,147
+118,920
+26% +$948K 0.01% 938
2013
Q2
$3.47M Buy
+449,227
New +$3.47M ﹤0.01% 1010